Position in JNJ
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$3,266,054
+$68,046 QoQ
Shares Held
12,860
-1.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.48%
of 13F equity value
Holder Rank
#1,934
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Lantz Financial LLC holds $16,892,877 across 12 Drug Manufacturers - General names. JNJ ranks #1 (19.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
12,860 | $3,266,054 | |
| 2 | LLY |
ELI LILLY & Co
|
2,003 | $2,402,458 | |
| 3 | MRK |
Merck & Co., Inc.
|
17,221 | $2,212,898 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
16,595 | $2,096,612 | |
| 5 | ABBV |
AbbVie Inc.
|
8,202 | $2,063,951 | |
| 6 | NVS |
Novartis AG
|
7,596 | $1,190,445 | |
| 7 | PFE |
Pfizer Inc
|
46,747 | $1,125,667 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
12,833 | $739,437 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,266,054 | 12,860 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $3,198,008 | 13,083 | Shares | Sole | 2026-04-09 | |
| 2025-12-31 | $2,986,081 | 14,429 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $2,826,357 | 15,243 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,816,503 | 11,892 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $1,985,768 | 11,974 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $1,677,158 | 11,597 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $1,835,167 | 11,324 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $1,476,362 | 10,101 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $1,619,232 | 10,236 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $1,620,378 | 10,338 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $1,548,622 | 9,943 | Shares | Sole | 2023-10-20 | |
| 2023-06-30 | $1,638,648 | 9,900 | Shares | Sole | 2023-07-12 | |
| 2023-03-31 | $1,550,155 | 10,001 | Shares | Sole | 2023-04-10 | |
| 2022-12-31 | $1,820,731 | 10,307 | Shares | Sole | 2023-01-23 | |
| 2022-09-30 | $1,663,331 | 10,182 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $1,816,282 | 10,232 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $1,810,227 | 10,214 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $1,741,321 | 10,179 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $1,669,264 | 10,336 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $1,655,801 | 10,051 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $1,627,229 | 9,901 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $1,547,517 | 9,833 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $1,402,747 | 9,422 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $1,277,623 | 9,085 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $1,134,930 | 8,655 | Shares | Sole | 2020-04-10 | |
| No filing history on record for this holder in this stock. | ||||||